Drug development advances in human genetics‐based targets

Drug development advances in human genetics‐based targets

Abstract Drug development is a long and costly process, with a high degree of uncertainty from the identification of a drug target to its market launch. Targeted drugs supported by human genetic evidence are expected to enter phase II/III clinical trials or be approved for marketing more quickly, sp...

Full description

Bibliographic Details
Main Authors: Xiaoxia Zhang, Wenjun Yu, Yan Li, Aiping Wang, Haiqiang Cao, Yuanlei Fu
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:MedComm
Subjects:
drug development
drug target
genetic variation
genome‐wide association studies
whole‐exome sequencing
whole‐genome sequencing
Online Access:https://doi.org/10.1002/mco2.481

Internet

https://doi.org/10.1002/mco2.481

Similar Items